ArticleEvolution, medicine, and public health2026
Exploring tumorigenesis as a process of phenotypic state-space exploration and selective funneling.
Article in Evolution, medicine, and public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Tumorigenesis is widely studied within evolutionary frameworks, yet integrating genetic, non-genetic, spatial, and collective tumor-level dynamics into a unified description remains challenging. Here, we propose that tumorigenesis can be analyzed as a process in which tumors generate, explore, and filter phenotypic and organizational configurations over time. We use the concepts of phenotypic state-space exploration, selective funneling, and selection for function as an operational framework to describe how tumor systems diversify, become constrained, and stabilize or lose functional organization during cancer progression. In this view, tumors are not only populations of competing clones, but also dynamic systems whose persistence depends on plasticity, tissue constraints, spatial organization, and collective functional states. This perspective helps account for phenotypic plasticity, recurrent tumor architectures, and the emergence of collective properties such as group phenotypic composition. It also generates testable predictions, including convergence toward recurrent functional states, therapy-induced reorganization of accessible phenotypic space, and the disproportionate effect of disrupting key collective functions. By mapping these concepts onto tumor biology, we position cancer as a tractable system for studying constraint-driven tumor evolution and for informing therapeutic strategies that target tumor organization in addition to individual cancer cells.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.